The holy grail – the development of a suitable vaccine against COVID-19
Interview about vaccine research with PD Dr. Michael Mühlebach The new coronavirus SARS-CoV-2 still dominates everyday life of many peaople worldwide. Nobody can say yet, when a return to "normality“ will be possible again without risking human lives. Hopes are high that the development of a vaccine will be successful which could protect the world population, or at least particularly vulnerable groups of people, from the new pathogen. The Paul Ehrlich Institute (PEI), the German Federal Institute for Vaccines and Biomedical Drugs, which is responsible for the approval of clinical trials and